Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Harvard Bioscience (HBIO) over the last 12 years, with Q1 2021 value amounting to $10.7 million.

  • Harvard Bioscience's Treasury Shares changed 0.0% to $10.7 million in Q1 2021 from the same period last year, while for Mar 2021 it was $10.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.7 million for FY2020, which is 0.0% changed from last year.
  • As of Q3 2025, Harvard Bioscience's Treasury Shares stood at $1.7 million, which was down 975.98% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Treasury Shares ranged from a high of $7.7 million in Q1 2021 and a low of $860155.0 during Q4 2021
  • For the 5-year period, Harvard Bioscience's Treasury Shares averaged around $1.9 million, with its median value being $1.6 million (2022).
  • Over the last 5 years, Harvard Bioscience's Treasury Shares had its largest YoY gain of 0.0% in 2017, and its largest YoY loss of 0.0% in 2017.
  • Harvard Bioscience's Treasury Shares (Quarter) stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
  • Its Treasury Shares was $10.7 million in Q1 2021, compared to $10.7 million in Q4 2020 and $10.7 million in Q3 2020.